STANDARDIZATION OF A 486/33 PC BASED TEST OF IMPAIRMENT

项目目标是构建和评估基于PC的测试 酒精引起的损伤将被分发到研究中 全美各地的实验室。我们的目标是开发一种 电脑化损伤检测的标准数据库。L阶段 Project生成从硬件测试派生的低成本软件测试 (Sedi)，有研究记录。SEDI提供了可靠的基线， 对低呼吸酒精浓度(BAC)的敏感性和线性剂量反应 与BAC的关系。新软件将在 以下是科学和商业市场：1)作为科学工具 酒精和药物实验室；2)作为评估和教育的测试 关于饮酒对驾驶性能的影响；3)作为一种程序 评价CNS类化合物对药物的损伤作用 行业；4)作为对其职业生涯的员工的筛选程序 绩效对公共健康、安全或福利至关重要。阶段 包括新旧测试的基线比较和剂量反应 评估饮酒对新测试成绩的影响。 这些研究将对不同年龄段的女性和男性进行抽样。这个 一期软件将分发给九个独立的酒精/药物 研究中心进一步规范考试。

The project objectives are to construct and evaluate a PC-based test of alcohol-induced impairment that will be distributed to research laboratories throughout the United States. The goal is to develop a normative database for computerized impairment testing. The Phase l project produces a low cost, software test derived from a hardware test (SEDI) with a research track record. SEDI yields reliable baselines, sensitivity to low breath alcohol levels (BACs) and a linear dose-response relationship with BACs. The new software will have application in the following scientific and commercial markets: 1) as a scientific tool in alcohol and drug laboratories; 2) as a test for evaluating and educating about the effects of drinking on driving performance; 3) as a procedure to evaluate the impairing effects of CNS compounds for the pharmaceutical industry; 4) as a screening procedure for employees whose occupational performance is critical to public health, safety, or welfare. Phase includes a baseline comparison of new and old tests and a dose-response evaluation of the effect of alcohol consumption on new test performance. The studies will sample females and males across diverse age groups. The Phase Il software will be distributed to nine independent alcohol/drug research centers to further standardize the test.